IN BRIEF: Ovoca Bio Pretax Loss Widens In First Half Of 2020

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Like last year, posts no ...

Alliance News 21 September, 2020 | 9:19PM
Email Form

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Like last year, posts no revenue in six months to June 30. Pretax loss widens to EUR2.0 million from EUR439,000. Posts EUR1.1 million in other losses, compared to gains to EUR463,000 a year earlier.

Current stock price: 14.00 pence

Year-to-date change: up 19%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Ovoca Bio PLC 10.25 GBX -4.65 -
Ovoca Bio PLC 0.13 EUR 17.27 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies